CRISPR gene therapy eliminates blood transfusions in 91% of β-thalassemia patients

Key Findings

🌾 Soybean gene editing reaches 81% efficiency with new prime editor

• Scientists developed GmPEplus, an optimized prime editing system that achieved up to 81.3% editing efficiency in stable soybean lines—a major leap for plant genome editing

• The system can simultaneously edit 2-12 genes in soybean root cultures and up to 3 genes in stable transgenic plants using a multiplex approach

• Key improvements included deleting the RNase H domain, adding viral proteins, and co-expressing a modified version of the plant's own DNA repair gene

🎯 New base editors achieve near-perfect precision without DNA damage

• Researchers combined SpRY (a near-PAM-less Cas9) with truncated deaminases to edit virtually any cytosine in the genome with minimal off-target effects

• Adding HMGN1 and VP64 proteins boosted editing efficiency without compromising precision, working effectively in both yeast and rice

• The system overcomes two major limitations: the need for specific PAM sequences near target sites and unwanted bystander editing of nearby bases

🧠 Non-viral CRISPR corrects hemophilia B in mice using lipid nanoparticles

• Lipid nanoparticles delivered base editor mRNA to correct specific hemophilia B mutations in mice, achieving 35.9-70.6% correction rates depending on the mutation

• The treatment restored blood clotting factor IX activity without using viral vectors, avoiding immune responses and re-dosing limitations of current gene therapies

• Six different nonsense mutations were successfully corrected in cell culture, demonstrating personalized treatment potential

🔍 AI-enhanced CRISPR diagnostics detect Alzheimer's markers with 10,000x sensitivity

• A new detection platform simultaneously measured six Alzheimer's biomarkers (including amyloid-β and phosphorylated tau) with a detection limit of 1 fg/mL—10,000 times more sensitive than standard ELISA tests

• Machine learning integration of the six biomarkers significantly outperformed single-biomarker approaches in diagnosing Alzheimer's disease and mild cognitive impairment in 155 plasma samples

• The system combines antibody-based amplification with CRISPR-Cas12a detection for ultrasensitive protein measurement

🍺 Gene-edited yeast boosts whisky's rose-like aroma by 23%

• CRISPR deletion of the ARO8 gene in Saccharomyces cerevisiae increased 2-phenylethanol (the compound responsible for rose-like aromas) from 0.59 g/L to 0.73 g/L in whisky

• Optimizing fermentation conditions further boosted 2-phenylethanol to 3.68 g/L—more than 6 times the original level

• The modification enhanced flavor without affecting yeast viability or other fermentation characteristics

🩺 CRISPR screen reveals new drug target for liver iron overload

• Base editing corrected the C282Y mutation causing hereditary hemochromatosis in up to 67% of mouse liver cells and 63.8% of patient-derived cells

• Treated mice showed significantly reduced liver iron accumulation and decreased fibrosis markers despite continued high-iron diets

• No off-target effects were detected at genomic sites with one or two DNA mismatches, suggesting a favorable safety profile